TipRanks
Go Ultimate55% OFF

Grown Rogue International (GRUSF) AI Stock Analysis

31 Followers
GRUSF

Grown Rogue International

(Other OTC:GRUSF)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Revenue growth and gross marginStrong TTM revenue growth combined with a healthy gross margin shows that the company is expanding while retaining meaningful economics on sales. Improved operating cash flow further supports day-to-day funding and provides a foundation for reinvestment as the business scales.
Negative Factors
Ongoing losses and earnings volatilityNegative EBIT and net income show that revenue growth has not yet translated into consistent bottom-line profitability. The swing from strong profitability in 2025 to a TTM loss also reduces confidence in the current earnings run-rate and leaves the business more exposed if operating costs remain elevated.

Grown Rogue International (GRUSF) vs. SPDR S&P 500 ETF (SPY)

-30%-20%-10%0%10%20%30%40%50%GRUSF+4.29%SPY+15.63%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
$91.23M
Dividend Yield
―
Average Volume (3M)
121.99K
Price to Earnings (P/E)
-24.0
Beta (1Y)
1.66
Revenue Growth
35.58%
EPS Growth
-311.71%
Country
US
Employees
204
Sector
Healthcare
Sector Strength
51
Industry
Drug Manufacturers - Specialty & Generic

Grown Rogue International Business Overview & Revenue Model

Company Description

Grown Rogue International Inc., operating through its various subsidiaries, specializes in the cultivation and distribution of diverse cannabis products across the United States. Its comprehensive product portfolio features an assortment of cannabis...

Grown Rogue International Earnings Call Summary

Earnings Call Date:Aug 03, 2026(Q2-2026)|% Change Since:-11.19%|Next Earnings Date:Mar 31, 2020
Earnings Call SentimentPositive

The call was overall positive: management reported record operational performance (notably in Michigan), clear progress on multi-state expansion (NJ, IL, MN), modest price recovery in Oregon, and demonstrated capital allocation discipline. Lowlights are largely operational/startup frictions, an ASP reporting distortion from a shake-based product in New Jersey, regulatory timing uncertainty in new states, and ongoing industry pricing volatility. The highlights — particularly the record cost and yield metrics, expanding capacity, and raised guidance supported by visibility — materially outweigh the manageable challenges discussed.

Positive Updates

Record production efficiency in Michigan
Michigan delivered record yields and low costs: ~90 grams per square foot of flower and ~$277 per pound (flower-only). Management reported full-biomass costs below $200 per pound. Team execution set a new internal benchmark the company expects to replicate across other markets.

Negative Updates

New Jersey yields and costs below internal benchmark
New Jersey yields and cost metrics are not yet at the levels seen in Michigan or Oregon. Management cited higher power and slightly higher labor costs, and the impact of carrying fixed/management costs on partially utilized capacity, driving higher per-unit expenses until full buildout (16,000 sq ft) is complete.

Company Guidance

Management guidance emphasized capacity buildouts and replicating Michigan-level efficiency: New Jersey is expected to reach full 16,000 sq ft flowering capacity (three additional flower rooms plus a mother room) by year‑end (100% of packaged flower sales this quarter and some bulk purchases to meet demand); Illinois had plants in June with first harvest expected in September and canopy expanding from an initial 5,000 sq ft to an approved 10,000 sq ft by year‑end; Minnesota plans to bring plants in August, harvest by year‑end and begin sales in Q1 2027. Operational targets call for matching Michigan’s record 90 grams/sq ft flower and $277/lb flower‑only cost (sub‑$200/lb full biomass), with management citing 90–100 g/sq ft and sub‑$300/lb flower as the new standard (sub‑$400–$500 and lower benchmarks cited as achievable), noting tech upgrades can be installed for low six‑figure costs; capital allocation aims to generate ~$0.75 of operating profit for every $1 invested after 12–18 months, the company reported Michigan excise tax as revenue, and it excluded a Yeti Ready‑to‑Roll SKU (shake normally ~$250/lb sold as ready‑to‑roll at ~ $1,000/lb) from flower ASP calculations.

Grown Rogue International Risk Analysis

Grown Rogue International disclosed 56 risk factors in its most recent earnings report. Grown Rogue International reported the most risks in the "Finance & Corporate" category.

Higher RiskSector Avg.Lower RiskFinance & CorporateTech & InnovationLegal & RegulatoryProductionAbility to SellMacro & Political
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy

Latest Risks Added

0 New Risks

Grown Rogue International Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

GRUSF against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
TSE:XLYTSE:XLY83OutperformCAD 379.91M11.0518.12%―18.79%10.74%
TSE:LOVETSE:LOVE77OutperformCAD 206.45M18.059.45%―14.66%-33.72%
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%
TSE:JUSHTSE:JUSH50NeutralCAD 143.79M-1.7440.14%―5.37%17.78%

* Healthcare Sector Average

Performance Comparison

-25%0%25%50%GRUSFTSE:JUSHTSE:XLYTSE:LOVEDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
GRUSF and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
GRUSFGrown Rogue International 0.360.001.11%
TSE:JUSHJushi Holdings Inc0.66-0.12-15.38%
TSE:XLYAuxly Cannabis Group (Otc)3.681.5169.59%
TSE:LOVECannara Biotech, Inc.2.050.4225.77%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.